title: Haematological malignancies presenting with acute liver injury: a single-centre experience.
abstract: BACKGROUND
  Early recognition and identification of the underlying cause of acute liver injury (ALI) is crucial in instituting medical treatment and assessing the need for liver transplantation. Haematological malignancies have been reported to present as ALI with progression to acute liver failure but experience is limited.
  
  
  OBJECTIVE
  Review our experience of ALI secondary to haematological malignancies.
  
  
  METHODS
  Patients admitted to the liver unit with ALI secondary to a haematological malignancy between 1996 and 2006 were identified. A retrospective review was made of their case notes and our database.
  
  
  RESULTS
  Of the 752 cases of ALI, six cases of ALI secondary to haematological malignancy were identified. Common features were a prodromal illness (median duration of 5 weeks; range 2-6 weeks) and jaundice (median bilirubin 208 micromol/l; range 112-238 micromol/l). The majority of patients (5/6) had hepatomegaly. Liver biopsy was performed in two patients and confirmed the diagnosis in both cases. In other cases, the diagnosis was made following lymph node biopsy (1), bone marrow examination (2) or from post-mortem examination (1). Median time from jaundice to encephalopathy was 12 days; range 1-22 days. A single patient underwent liver transplantation but died in the immediate post-operative period. All patients died soon after admission with a median survival of 8 days (range 3-26 days).
  
  
  CONCLUSIONS
  Haematological malignancy should be considered in ALI patients presenting with a prodromal illness, jaundice and hepatomegaly. Biopsy is essential to confirm the diagnosis but the benefit of definitive therapy such as chemotherapy and/or transplantation in this setting is unclear and survival is poor.
authors.affiliation: Liver Unit, Queen Elizabeth Hospital, Birmingham, UK. S.Shetty@bham.ac.uk
authors.forename: S
authors.initials: S
authors.lastname: Shetty
authors.forename: A P
authors.initials: AP
authors.lastname: Holt
authors.forename: W-K
authors.initials: WK
authors.lastname: Syn
authors.forename: C P
authors.initials: CP
authors.lastname: Fox
authors.forename: B
authors.initials: B
authors.lastname: Gunson
authors.forename: D
authors.initials: D
authors.lastname: Neil
authors.forename: G
authors.initials: G
authors.lastname: Haydon
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007565:Jaundice / Q000209:etiology; D008107:Liver Diseases / Q000175:diagnosis / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D055815:Young Adult